Aclaris Therapeutics, Inc. · NASDAQ:ACRS

BML Investment Partners, L.P. reported a 13.30% stake in Aclaris Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 13, 2025

BML Investment Partners, L.P. reported a 13.30% stake in Aclaris Therapeutics, Inc., 14,250,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 13, 2025 (Schedule 13G/A).

Stake
13.30%
Shares
14,250,000
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BML Investment Partners, L.P.13.30%14,250,000

Source

View original at SEC

Related